KurtRichardOlsonMD

Family Medicine • Munising, MI

Physician

Join to view full profile

Dr. Olson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Olson's full profile

Already have an account?

Office
1504 Sandpoint Rd
Munising, MI 49862
Phone+1 906-387-4220

Fax+1 906-387-5449
Is this information wrong?

Education & Training

AdventHealth Florida (East Orlando)Residency, Family Medicine, 1989 - 1992
Loma Linda University School of MedicineClass of 1989

Certifications & Licensure

MI State Medical License 1991 - 2025
WI State Medical License 1992 - 1995
FL State Medical License 1990 - 1994
WA State Medical License 1992 - 1993
MN State Medical License 1992 - 1993
American Board of Family Medicine Family Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Kareo, 2012-2013

Publications & Presentations

PubMed

10 citations
Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure) Clinica...
Peter van der Meer, Niels Grote Beverborg, Marc A. Pfeffer, Kurt Olson, Inder S. Anand, B. Daan Westenbrink, John J.V. McMurray, Karl Swedberg, James B. Young, Scott D...> ;Circulation. Heart Failure. 2018 Feb 1
6 citations
De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease.
Bradley A. Warady, John Barcia, Nadine Benador, Augustina Jankauskiene, Kurt Olson, Ludmila Podracka, Aleksey Shavkin, Poyyapakkam Srivaths, Cynthia J. Wong, Jeffrey P...> ;Pediatric Nephrology. 2018 Jan 1
31 citations
Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Tri...
Marwa A. Sabe, Brian Claggett, Emmanuel A. Burdmann, Akshay S. Desai, Peter Ivanovich, Reshma Kewalramani, Eldrin F. Lewis, John J.V. McMurray, Kurt Olson, Patrick S. ...> ;Journal of the American Heart Association. 2016 Apr 1
30 citations
Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease
Natalie A. Bello, Eldrin F. Lewis, Akshay S. Desai, Inder S. Anand, Henry Krum, John J.V. McMurray, Kurt Olson, Scott D. Solomon, Karl Swedberg, Dirk J. van Veldhuisen...> ;European Journal of Heart Failure. 2015 Oct 1
34 citations
Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia.
Natalie A. Bello, Marc A. Pfeffer, Hicham Skali, Janet B. McGill, Jerome Rossert, Kurt Olson, Larry A. Weinrauch, Mark E. Cooper, Dick de Zeeuw, Peter Rossing, John J....> ;BMJ Open Diabetes Research & Care. 2014 Apr 1
2 citations
Evaluating statistical methods to establish clinical similarity of two biologics.
Lei Lei, Kurt Olson> ;Journal of Biopharmaceutical Statistics. 2009 Dec 31
128 citations
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and Design Overview
Glenn M. Chertow, Lara B. Pupim, Geoffrey A. Block, Ricardo Correa-Rotter, Tilman B. Drüeke, Jürgen Floege, William G. Goodman, Gérard M. London, Kenneth W. Mahaffey, ...> ;Clinical Journal of the American Society of Nephrology. 2007 Sep 1
44 citations
Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism.
J. R. Sterrett, James A. Strom, H-K. Stummvoll, Udo Bahner, Alexander Patrick Suffe Disney, S. D. Soroka, C. Corpier, J. A. Arruda, L. E. Schwanauer, Preston S. Klasse...> ;Clinical Nephrology. 2007 Jul 1
352 citations
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism.
John Cunningham, Mark D. Danese, Kurt Olson, Preston S. Klassen, Glenn M. Chertow> ;Kidney International. 2005 Oct 1
224 citations
Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl
Sharon M. Moe, Glenn M. Chertow, Jack W. Coburn, L. Darryl Quarles, William G. Goodman, Geoffrey A. Block, Tilman B. Drüeke, John Cunningham, Donald J. Sherrard, Laura...> ;Kidney International. 2005 Feb 1
769 citations
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Geoffrey A. Block, Kevin J. Martin, Angel L.M. de Francisco, Stewart A. Turner, Morrell M. Avram, Michael Suranyi, Gavril Hercz, John Cunningham, Ali K. Abu-Alfa, Pier...> ;The New England Journal of Medicine. 2004 Apr 8
51 citations
Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysis.
Michael Allon, Ken Kleinman, Michael Walczyk, Charles Kaupke, Louise Messer-Mann, Kurt Olson, Anne C. Heatherington, Bradley J. Maroni> ;Clinical Pharmacology and Therapeutics. 2002 Nov 1
44 citations
Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease.
Gary Lerner, Arundhati S. Kale, Bradley A. Warady, Kathy Jabs, Timothy E. Bunchman, Anne C. Heatherington, Kurt Olson, Louise Messer-Mann, Bradley J. Maroni> ;Pediatric Nephrology. 2002 Sep 14
Join now to see all